Bullish call on GE Healthcare

01:49pm, Tuesday, 16'th May 2023
The "Halftime Report" traders debate the biggest analyst calls of the day.
Increasingly, technologies other than drugs are working to improve patient health. From diagnostic systems like MRIs and CAT scans to high-tech glucose monitoring systems to devices that destroy tumor
GEHC, $81.52, Market Capitalization $37.1 billion), a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, reported 1Q23 results with a beat on both revenue
GE HealthCare Technologies Inc is not a start-up though it is a new public company. It's a spin-off of a legacy company with seasoned management operating in a growing industry. The recent slip of abo

Why GE Healthcare Stock Fell 9% Today

11:41am, Tuesday, 25'th Apr 2023
GE HealthCare beat on the top and bottom lines this morning -- but warned of a likely earnings miss for the year. Revenues grew and earnings sank in Q1, but both numbers look likely to rise later in t
GE HealthCare Technologies Inc, the General Electric (NYSE:GE) spinoff, beat first-quarter earnings and revenue expectations in its second quarter as a standalone company.  That hasn't stopped the me
GE HealthCare reported a strong first quarter. The stock is sliding probably because investors are taking profits to lock in a 50% year-to-date gain.
GE HealthCare Technologies Inc. GEHC posted better-than-expected first-quarter earnings on Tuesday, its second quarter reporting as a spinoff from General Electric Co. GE. The Chicago-based company po
The company split off from GE in January. GE HealthCare has been active in mergers and acquisitions.
GEHC and GE earnings are both due early Tuesday. Both stocks are up more than 50% since the start of the year.
Piper Sandler analyst Jason Bednar initiated coverage of the company with the equivalent of a Buy rating and $95 price target.
Finding S&P 500 stocks that analysts agree on is rare. So when you see nearly unanimous agreement on some, that's quite a statement.
Embecta should benefit from the greater need for diabetic services. Viatris is focusing on finding new generics.
Stephanie Link, chief investment strategist and portfolio manager at Hightower Advisors, joins 'Closing Bell' to discuss what the market is looking through as the banking stocks have been hit followin
Investments in AI, digital technology, software, and other add-on services promise to expand the company's margins. It continues to introduce new products.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE